Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System

Update Item Information
Title Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System
Creator Howard D. Pomeranz, MD, PhD
Affiliation Department of Ophthalmology, North Shore Long Island Jewish Health System and Hofstra-North Shore LIJ School of Medicine, Great Neck, New York
Subject Adverse Drug Reaction Reporting Systems / statistics & numerical data; Erectile Dysfunction / drug therapy; Humans; Male; Optic Neuropathy, Ischemic / chemically induced; Phosphodiesterase 5 Inhibitors / adverse effects; Phosphodiesterase 5 Inhibitors / therapeutic use; United States; United States Food and Drug Administration
OCR Text Show
Date 2016-06
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Source Journal of Neuro-Ophthalmology, June 2016, Volume 36, Issue 2
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s67d6pnw
Setname ehsl_novel_jno
ID 1276505
Reference URL https://collections.lib.utah.edu/ark:/87278/s67d6pnw
Back to Search Results